(Total Views: 82)
Posted On: 12/06/2023 2:45:48 PM
Post# of 47046
$GERN News Article - Geron Announces Fifty Percent Enrollment in the Phase 3 IMpactMF Clinical Trial Evaluating Imetelstat in Patients with Relapsed/Refractory Myelofibrosis https://marketwirenews.com/news-releases/gero...60343.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
